Bryan helps clients win in the market.
Bryan helps each client define what “winning” means to them, then assists with crafting and executing a strategy to help clients achieve their goals. Although Bryan’s technical acumen lies in intellectual property, he often works hand-in-hand with other Husch Blackwell team members to provide holistic guidance to clients.
An engineer who shifted to a legal career out of a desire for more strategic-minded work and to help clients on a larger scale, Bryan takes a strategy-driven view of clients’ IP assets. He seeks to provide legal advice that focuses on which assets and legal actions truly add value and meet client business goals—drawing on his experience to determine the most valuable IP and how best to protect and leverage IP for market advantage.
On intellectual property matters, he provides strategic advice and counseling, domestic and global portfolio management, representing clients with hundreds of IP assets that include patents, trademarks, and copyrights. Bryan’s counsel touches on risk avoidance, freedom to operate, patentability, pre-litigation dispute counseling and cease-and-desist letters, infringement analysis, licensing agreements, and patent prosecution and mark registration, all with a view of helping clients succeed over the long term.
Bryan works with a broad spectrum of clients, especially those in the life science, medical device, software, machine learning and AI, Internet of Things (IoT), and energy/hydro spaces. He has developed particular knowledge related to additive manufacturing and at the intersection of software and hardware within the medical device space. He routinely represents clients who are developing devices that rely on the Internet of Things (IoT), and he oversees a niche practice representing companies who design and manufacture patient-specific medical devices dependent on additive manufacturing/3D printing.
Although Bryan has a client roster today that spans companies at all stages of growth, he first cut his teeth on startups and continues to have a special emphasis in the area. Bryan has worked on hundreds of mergers, acquisitions, company sales, and investments, and leverages this experience to help startup clients grow with a view towards investment, exit, or IPO. Relatedly, Bryan frequently performs IP due diligence during corporate transactions both buy-side and sell-side.
Bryan is the co-leader of the firm's Life Sciences industry team.